103 related articles for article (PubMed ID: 10672975)
1. Repeated treatments with 7-OH-DPAT: context-independent behavioral sensitization and conditioned hyperactivity.
Mattingly BA; Rice LL; Langfels M; Fields SE
Pharmacol Biochem Behav; 2000 Feb; 65(2):241-6. PubMed ID: 10672975
[TBL] [Abstract][Full Text] [Related]
2. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT.
Mattingly BA; Himmler C; Bonta T; Rice LL
Psychopharmacology (Berl); 1998 Dec; 140(4):387-97. PubMed ID: 9888612
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of 7-OH-DPAT on the development of behavioral sensitization to apomorphine and cocaine.
Mattingly BA; Caudill A; Abel M
Pharmacol Biochem Behav; 2001 Mar; 68(3):417-26. PubMed ID: 11325394
[TBL] [Abstract][Full Text] [Related]
4. Repeated 7-OH-DPAT treatments: behavioral sensitization, dopamine synthesis and subsequent sensitivity to apomorphine and cocaine.
Mattingly BA; Fields SE; Langfels MS; Rowlett JK; Robinet PM; Bardo MT
Psychopharmacology (Berl); 1996 May; 125(1):33-42. PubMed ID: 8724446
[TBL] [Abstract][Full Text] [Related]
5. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors.
Rogóz Z; Skuza G
Pol J Pharmacol; 2001; 53(6):571-6. PubMed ID: 11985330
[TBL] [Abstract][Full Text] [Related]
6. A dose-response study of separate and combined effects of the serotonin agonist 8-OH-DPAT and the dopamine agonist quinpirole on locomotor sensitization, cross-sensitization, and conditioned activity.
Johnson EF; Szechtman H
Behav Pharmacol; 2016 Aug; 27(5):439-50. PubMed ID: 26871406
[TBL] [Abstract][Full Text] [Related]
7. Behavioral interactions produced by co-administration of 7-OH-DPAT with cocaine or apomorphine in the rat.
Khroyan TV; Fuchs RA; Beck AM; Groff RS; Neisewander JL
Psychopharmacology (Berl); 1999 Mar; 142(4):383-92. PubMed ID: 10229063
[TBL] [Abstract][Full Text] [Related]
8. Bromocriptine and quinpirole, but not 7-OH-DPAT or SKF 38393, potentiate the inhibitory effect of L-NAME on ethanol-induced locomotor activity in mice.
Uzbay IT; Kayir H
Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):414-21. PubMed ID: 12690434
[TBL] [Abstract][Full Text] [Related]
9. Effects of intra-amygdala R(+) 7-OH-DPAT on intra-accumbens d-amphetamine-associated learning. I. Pavlovian conditioning.
Hitchcott PK; Phillips GD
Psychopharmacology (Berl); 1998 Dec; 140(3):300-9. PubMed ID: 9877010
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of 7-OH-DPAT on amphetamine-induced stereotypy and conditioned place preference.
Khroyan TV; Baker DA; Fuchs RA; Manders N; Neisewander JL
Psychopharmacology (Berl); 1998 Oct; 139(4):332-41. PubMed ID: 9809854
[TBL] [Abstract][Full Text] [Related]
11. Effects of intra-amygdala R(+) 7-OH-DPAT on intra-accumbens d-amphetamine-associated learning. II. Instrumental conditioning.
Hitchcott PK; Phillips GD
Psychopharmacology (Berl); 1998 Dec; 140(3):310-8. PubMed ID: 9877011
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent effects of the D3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning.
Khroyan TV; Baker DA; Neisewander JL
Psychopharmacology (Berl); 1995 Dec; 122(4):351-7. PubMed ID: 8657832
[TBL] [Abstract][Full Text] [Related]
13. The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference.
Rodríguez De Fonseca F; Rubio P; Martín-Calderón JL; Caine SB; Koob GF; Navarro M
Eur J Pharmacol; 1995 Feb; 274(1-3):47-55. PubMed ID: 7768280
[TBL] [Abstract][Full Text] [Related]
14. 7-OH-DPAT effects on latent inhibition: low dose facilitation but high dose blockade: implications for dopamine receptor involvement in attentional processes.
Chagas-Martinich L; Carey RJ; Carrera MP
Pharmacol Biochem Behav; 2007 Mar; 86(3):441-8. PubMed ID: 17291574
[TBL] [Abstract][Full Text] [Related]
15. Altered behavioral response to dopamine D3 receptor agonists 7-OH-DPAT and PD 128907 following repetitive amphetamine administration.
Richtand NM; Welge JA; Levant B; Logue AD; Hayes S; Pritchard LM; Geracioti TD; Coolen LM; Berger SP
Neuropsychopharmacology; 2003 Aug; 28(8):1422-32. PubMed ID: 12700693
[TBL] [Abstract][Full Text] [Related]
16. 7-OH-DPAT, unlike quinpirole, does not prime a yawning response in rats.
Oswiecimska J; Brus R; Szkilnik R; Nowak P; Kostrzewa RM
Pharmacol Biochem Behav; 2000 Sep; 67(1):11-5. PubMed ID: 11113478
[TBL] [Abstract][Full Text] [Related]
17. Effects of putative dopamine D3 receptor agonists, 7-OH-DPAT, and quinpirole, on yawning, stereotypy, and body temperature in rats.
Kurashima M; Yamada K; Nagashima M; Shirakawa K; Furukawa T
Pharmacol Biochem Behav; 1995 Nov; 52(3):503-8. PubMed ID: 8545466
[TBL] [Abstract][Full Text] [Related]
18. The locomotor effects of a putative dopamine D3 receptor agonist in developing rats.
Frantz K; Babcock D; Van Hartesveldt C
Eur J Pharmacol; 1996 Apr; 302(1-3):1-6. PubMed ID: 8790984
[TBL] [Abstract][Full Text] [Related]
19. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
[TBL] [Abstract][Full Text] [Related]
20. Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat.
Uvnäs-Moberg K; Ahlenius S; Alster P; Hillegaart V
Neuroendocrinology; 1996 Mar; 63(3):269-74. PubMed ID: 8677015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
